Raising Awareness on Managing Competing Interests in a Multi-Stakeholder Environment: Guidance to Patients and Engaging Stakeholders – download the guidance below Background/Rationale for the document...
Enhancement of the EUPATI industry guidance Background/Rationale for the documents During the PARADIGM project further expansion of specific sections of the EUPATI Guidance for Patient...
Recommendations on the required capabilities for patient engagement Background/Rationale for the document This tool provides recommendations on the competencies (understood as knowledge, skills and behaviours)...
For collaborations between the patient community and stakeholders in the health care system. 1. Introduction PARADIGM (Patients active in research and dialogues for an improved...
Patient engagement in medicines development: Recommendations on how to find the right match for the right patient engagement activity. Background/Rationale for the document During the...
Code of Conduct for all stakeholders involved in patient engagement activities within medicines development. Background/Rationale There is no European or international legislation defining the rules...
Working with Community Advisory Boards: Guidance and tools for patient communities and pharmaceutical companies Background/Rationale for the document Community Advisory Boards (CABs) can improve research...
Patient Engagement in Early Dialogues: Tools and resources for HTA bodies Background/Rationale Early Dialogues with regulators and health technology assessment (HTA) bodies are a well-established...
Patient Engagement Monitoring and Evaluation Framework Background/Rationale for the document: Capturing the ‘return on engagement’ is complex, given the many factors that influence the impact...
Guidance for Reporting and Dissemination of Patient Engagement Activities Background/Rationale for the document The complete and reliable reporting and dissemination of all patient engagement...
